Yirui Wang

Title: Innovations by Yirui Wang in Protein Inhibition

Introduction

Yirui Wang is an accomplished inventor based in Hefei, China. He has made significant contributions to the field of protein inhibitory medicines, holding 2 patents that showcase his innovative approaches to targeting specific protein activities.

Latest Patents

One of his latest patents is titled "Use of compound or medicinal derivative thereof in inhibiting AIM2 protein activity." This invention provides a compound that effectively inhibits the activity of the absent in melanoma 2 (AIM2) protein. Compared to traditional broad-spectrum immunomodulators, this compound demonstrates a strong targeting effect, making it more accurate, rapid, effective, safe, and stable. The compound exhibits a strong binding force with both human and mouse AIM2 proteins, with binding constants as high as K=1.56EM and K=5.12EM, respectively. Additionally, it offers advantages such as easy storage, stable activity, small molecular weight, lower production cost, and easy absorption.

Another notable patent by Wang is "Use of compound or pharmaceutical derivative thereof in inhibiting CaMK2G protein activity." This invention focuses on inhibiting the calcium/calmodulin-dependent protein kinase type II gamma (CaMK2γ) protein activity. Similar to his previous patent, this compound also shows a strong targeting effect and is more accurate, rapid, effective, safe, and stable than traditional broad-spectrum immunomodulators. The binding constants for this compound with human-derived and mouse-derived CaMK2γ proteins are KD=2.54×10M and KD=6.84×10M, respectively. The advantages of this compound include easy storage, stable activity, small molecular weight, lower production cost, and easy absorption.

Career Highlights

Throughout his career, Yirui Wang has worked with various companies, including Liangdan Sun. His innovative work in the field of protein inhibitors has positioned him as a notable figure in the scientific community.

Collaborations

Wang has collaborated with several professionals, including Weiwei Chen and Liangdan Sun, contributing to advancements in protein inhibition technologies.

Conclusion

Yirui Wang's contributions to the field of protein inhibitory medicines through his innovative patents highlight his expertise and dedication to advancing medical science. His work continues to pave the way for more effective treatments in the future.